Metabolomics Australia (MA): focused on providing customised service for small molecule analysis, access to world class expertise, analytical technologies and bioinformatics. Breadth of capability across biotechnology, diagnostics, environmental, agriculture, food/beverage and biomedical sciences. Providing specific detection, quantification services and catering to complex investigations and systems wide analyses. ENABLING INNOVATION.

The CDCO is an innovative collaborative research centre that provides ADME lead candidate optimisation support and advice to emerging drug discovery programs. Drug candidate optimisation fills a crucial gap between discovery and development by integrating medicinal chemistry and biology with the pharmaceutical sciences to provide a rational means of identifying better drug candidates.